Efficacy, Immunogenicity and Cost Analysis of a Systematic Switch from Originator Infliximab to Biosimilar Ct-P13 of All Patients with Inflammatory Arthritis from a Single Center

AuthID
 P-00S-AE7
7
Author(s)
Valido, A
·
Silva Dinis, J
·
Saavedra, MJ
·
Iria, I
·
Goncalves, J
·
Lopes, JP
·
Document Type
Article
Year published
2019
Published
in ACTA REUMATOLOGICA PORTUGUESA, ISSN: 0303-464X
Volume: 44, Issue: 4, Pages: 303-311 (9)
Indexing
Wos®
Scopus®
Pubmed®
Publication Identifiers
Pubmed: 31754088
Scopus: 2-s2.0-85083623934
Wos: WOS:000539495400009
Source Identifiers
ISSN: 0303-464X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service